Login to Your Account

American Society of Clinical Oncology

Amgen's Aranesp Comparable To Procrit In Head-To-Head Trials

By Kim Coghill

Wednesday, June 9, 2004
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription